Table 1 Demographic and ocular characteristics
From: Evaluation of markers of outcome in real-world treatment of diabetic macular edema
Demographic characteristics (N = 122 patients; 68 RE and 54 LE) | |
|---|---|
Age (years) | |
Mean ± SD | 65.2 ± 8.9 |
Median (range) | 66 (46–85) |
Sex | |
Male | 66 (54.1%) |
Female | 56 (45.9%) |
Duration of diabetes (years) | |
1–15 | 55 (45.1%) |
16–25 | 52 (42.6%) |
> 25 | 15 (12.3%) |
HbA1c (%) | |
≤ 7 | 31 (25.4%) |
> 7 and < 8 | 44 (36.1%) |
≥ 8 | 47 (38.5%) |
Hypertensiona | |
Yes | 75 (61.5%) |
No | 47 (38.5%) |
Insulin | |
Yes | 64 (52.5%) |
No | 58 (47.5%) |
Ocular characteristics (N = 122 eyes) | |
Lens status | |
Phakic | 80 (65.6%) |
Pseudophakic | 42 (34.4%) |
Intravitreal injection received | |
RNZ only | 93 (76.2%) |
AFL only | 14 (11.5%) |
Both | 15 (12.3%) |
Laser | |
Yes | 68 (55.7%) |
No | 54 (44.3%) |
Baseline BCVA (L) | |
Mean ± SD | 63.2 ± 12.7 |
Median (range) | 67.0 (24.0–78.0) |
Baseline CRT (μm) | |
Mean ± SD | 432.4 ± 107.0 |
Median (range) | 400.5 (289.0–776.0) |
Baseline SFCT (μm) | |
Mean ± SD | 346.6 ± 75.6 |
Median (range) | 345.0 (124.0–580.0) |
Baseline EZ | |
Intact | 80 (65.6%) |
Disrupted | 41 (33.6%) |
Unreadable | 1 (0.8%) |
3 M EZ | |
Intact | 89 (73.0%) |
Disrupted | 33 (27.0%) |
Baseline SND | |
Yes | 27 (22.1%) |
No | 95 (77.9%) |